Pozen earns M milestone payment from AstraZeneca - Bizjournals.com

Pozen earns M milestone payment from AstraZeneca Bizjournals.com ... is a pain-reliever and anti-inflammatory drug being investigated for the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. ... FDA Accepts Pozen's NDA For Vimovo - UpdateRTT News FDA accepts new drug application from Pozen for arthritis drugLocal Tech Wire New Drug Application for VIMOVO accepted by US Food and Drug ...News-Medical.net all 45 news articles »

How can ankylosing spondylitis be treated? - DoctorNDTV

How can ankylosing spondylitis be treated? DoctorNDTV Treatment is based on the activity of ankylosing spondylitis disease process in your body. So, you will have to be in touch with your physician for the ...

Assessment of radiographic progression in the spines of patients ... - 7thSpace Interactive (press release)

Assessment of radiographic progression in the spines of patients ... 7thSpace Interactive (press release) ... pooled from the Adalimumab Trial Evaluating Long-Term Efficacy and Safety for Ankylosing Spondylitis (ATLAS) study and a Canadian AS study (M03-606). ...

Golimumab eases PsA: Benefits of once-monthly anti-TNF treatment ... - ModernMedicine

Golimumab eases PsA: Benefits of once-monthly anti-TNF treatment ... ModernMedicine Approved by the FDA in April for the treatment of moderate-to-severe psoriasis, psoriatic arthritis and ankylosing spondylitis, golimumab is an ...